Prosecution of Licensed Patents. (i) Emisphere shall, at least twice in each Calendar Year and at minimum intervals of five months, during the Term provide Novo Nordisk with a list of Licensed Patents providing relevant filing, priority, and status information (the “Semiannual Licensed Patent Report”), beginning on the date that is six (6) calendar months following the Effective Date.
Appears in 4 contracts
Samples: Development and License Agreement, Development and License Agreement (Emisphere Technologies Inc), Development and License Agreement (Emisphere Technologies Inc)